1. Home
  2. CRGO vs KPTI Comparison

CRGO vs KPTI Comparison

Compare CRGO & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

N/A

Current Price

$0.65

Market Cap

39.6M

Sector

Finance

ML Signal

N/A

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$0.09

Market Cap

36.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRGO
KPTI
Founded
2012
2008
Country
Spain
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.6M
36.7M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
CRGO
KPTI
Price
$0.65
$0.09
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$2.75
★ $7.25
AVG Volume (30 Days)
87.0K
★ 5.6M
Earning Date
11-23-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $146,067,000.00
Revenue This Year
$3.78
N/A
Revenue Next Year
$9.86
$27.98
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 0.57
52 Week Low
$0.63
$0.09
52 Week High
$4.24
$10.99

Technical Indicators

Market Signals
Indicator
CRGO
KPTI
Relative Strength Index (RSI) 34.47 29.59
Support Level N/A N/A
Resistance Level $1.43 $2.16
Average True Range (ATR) 0.06 0.13
MACD 0.01 0.03
Stochastic Oscillator 35.22 0.89

Price Performance

Historical Comparison
CRGO
KPTI

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: